SCHEMBL2808262

SCHEMBL2808262

CCCC[Sn](CCCC)(CCCC)OC(=O)CCC(=O)OC(C)C

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 6/20 0.58
MAPT P10636 6/20 0.39
MAPK1 P28482 5/20 0.39
ALDH1A1 P00352 1/20 0.37
CYP1A2 P05177 3/20 0.36
GMNN O75496 3/20 0.35
NPSR1 Q6W5P4 3/20 0.35
MEN1 O00255 2/20 0.35
HSP90AA1 P07900 2/20 0.35
BLM P54132 2/20 0.35
KMT2A Q03164 2/20 0.35
NR1H4 Q96RI1 2/20 0.35
TP53 P04637 1/20 0.35
CYP2C9 P11712 1/20 0.35
TSHR P16473 1/20 0.35
HIF1A Q16665 1/20 0.35
PRKCA P17252 1/20 0.34
PRKCE Q02156 1/20 0.34
PRKCQ Q04759 1/20 0.34
PRKCD Q05655 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2808152 0.87 DGKA (0.39) LMNAALDH1A1MEN1KMT2ATP53
SCHEMBL8562712 0.81 ALDH1A1 (0.46) LMNAALDH1A1TP53TSHR
SCHEMBL2569827 0.81 DGKA (0.47) LMNAMAPTMAPK1ALDH1A1TSHR
SCHEMBL5108551 0.78 DGKA (0.53) LMNAMAPTMAPK1ALDH1A1MEN1
SCHEMBL394258 0.78 DGKA (0.53) LMNAMAPTMAPK1ALDH1A1MEN1
SCHEMBL8401967 0.78 DGKA (0.53) LMNAMAPTMAPK1ALDH1A1MEN1
SCHEMBL127507 0.77 LMNA (0.83) LMNAMAPTMAPK1ALDH1A1CYP1A2
Butane SCHEMBL20558824 0.77 LMNA (0.68) LMNAMAPTMAPK1ALDH1A1TSHR
SCHEMBL10558076 0.77 DGKA (0.52) LMNAMAPTMAPK1ALDH1A1MEN1
SCHEMBL6560632 0.77 LMNA (0.36) LMNAMAPTALDH1A1CYP1A2FAAH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3034547-B1 A process for the preparation of a block copolymer comprising a first polyolefin block and a second polymer block SABIC GLOBAL TECHNOLOGIES BV (NL) 2019-10-09 EP claimed
EP-3034545-A1 A process for the preparation of a graft copolymer comprising a polyolefin main chain and one or a multiple polymer side chains and the products obtained therefrom SABIC Global Technologies B.V. (NL) 2016-06-22 EP claimed
EP-3034547-A1 A process for the preparation of a block copolymer comprising a first polyolefin block and a second polymer block and the products obtained therefrom SABIC Global Technologies B.V. (NL) 2016-06-22 EP claimed
EP-3577171-B1 AQUEOUS SYSTEM FOR FORMING A COATING ON A SUBSTRATE BASF SE (DE) 2020-11-18 EP disclosed
EP-3034545-B1 A PROCESS FOR THE PREPARATION OF A GRAFT COPOLYMER COMPRISING A POLYOLEFIN MAIN CHAIN AND ONE OR A MULTIPLE POLYMER SIDE CHAINS AND THE PRODUCTS OBTAINED THEREFROM SABIC GLOBAL TECHNOLOGIES BV (NL) 2020-11-04 EP disclosed
US-10815383-B2 Pigmented primer composition for forming an n-acyl urea coating BASF SE (DE) 2020-10-27 US disclosed
EP-3233974-B1 A PROCESS FOR THE PREPARATION OF A BLOCK COPOLYMER COMPRISING A FIRST POLYOLEFIN BLOCK AND A SECOND POLYMER BLOCK SABIC GLOBAL TECHNOLOGIES BV (NL) 2020-02-19 EP disclosed
EP-3328945-B1 PIGMENTED PRIMER COMPOSITION FOR FORMING AN N-ACYL UREA COATING BASF SE (DE) 2019-10-30 EP disclosed
US-10457767-B2 Method of preparing a polycarbodiimide polymer and polycarbodiimide polymer prepared thereby BASF SE (DE) 2019-10-29 US disclosed
EP-3034546-B1 A process for the preparation of a block copolymer comprising a first polyolefin block and a second polymer block SABIC GLOBAL TECHNOLOGIES BV (NL) 2019-10-16 EP disclosed
EP-3034544-B1 A process for the preparation of a graft copolymer comprising a polyolefin main chain and one or a multiple polymer side chains SABIC GLOBAL TECHNOLOGIES BV (NL) 2019-10-16 EP disclosed
WO-2009045941-A1 ENHANCED RETENTION CAPABILITIES THROUGH METHODS COMPRISING SURFACE TREATMENT OF FUNCTIONAL PARTICULATE CARRIER MATERIALS, AND FUNCTIONAL PARTICULATE CARRIER MATERIALS MADE THEREFROM WORLD MINERALS, INC. (US) 2009-04-09 WO disclosed
US-20060276339-A1 Methods and compositions for increasing the efficacy of biologically-active ingredients BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM 2006-12-07 US disclosed
US-6489503-B1 COMPOSITION COMPRISING METHYLENE BIS(PHENYLISOCYANATE) COMPONENT AND POSITIVE AMOUNT OF URETONIMINE, WHICH IS STORAGE STABLE AS LIQUID AT TEMPERATURE OF AT LEAST 30 DEGREES C. BASF CORPORATION 2002-12-03 US disclosed
US-6120699-A CONVERTING A PORTION OF THE 4,4'-MDI INTO A POSITIVE AMOUNT OF A CARBODIIMIDE, THE CARBODIIMIDE SUBSEQUENTLY BEING CONVERTED INTO A POSITIVE AMOUNT OF A URETONIMINE IN THE PRESENCE OF EXCESS 4,4'-MDI BASF CORPORATION (US) 2000-09-19 US disclosed
EP-0989116-A1 Storage stable methylene bis(phenylisocyanate) compositions Basf Corporation (US) 2000-03-29 EP disclosed
US-4424288-A Carbodiimide-modified polymethylene polyphenylene polyisocyanates for use in the preparation of polyisocyanurate-polyurethane foams BASF WYANDOTTE CORPORATION (US) 1984-01-03 US disclosed
US-4284730-A Liquid carbodiimide- and uretonimine-isocyanurate-containing polyisocyanate compositions and microcellular foams made therefrom BASF WYANDOTTE CORPORATION (US) 1981-08-18 US disclosed
US-4228095-A Process for the preparation of liquid carbodiimide-modified organic polyisocyanates employing organotin catalysts BASF WYANDOTTE CORPORATION (US) 1980-10-14 US disclosed
US-4018708-A TRANSESTERIFICATION CATALYSTS BASF WYANDOTTE CORPORATION (US) 1977-04-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060276339-A1 Methods and compositions for increasing the efficacy of biologically-active ingredients ENPP1, ENPP3, SMPD1 LMNA 3199/4885MAPT 4463/4885MAPK1 3407/4885
US-10457767-B2 Method of preparing a polycarbodiimide polymer and polycarbodiimide polymer prepared thereby PAICS, PBRM1, PARG LMNA 2029/4885MAPT 695/4885MAPK1 2502/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.